The BRASH acronym describes a syndrome involving bradycardia, renal failure, AV nodal blockade, shock, and hyperkalemia. The synergism between AV nodal blocking medications and hyperkalemia results in a life-threatening condition that requires prompt recognition and management. This activity reviews the evaluation and treatment of BRASH syndrome and highlights the role of the interprofessional team in evaluating and treating patients with this condition.

**Objectives:**
- Describe the pathophysiology of BRASH syndrome.
- Review the risk factors for developing the BRASH syndrome.
- Describe the presentation of a patient with BRASH syndrome.
- Summarize the management considerations for patients with BRASH syndrome.